![Eric Hyllengren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Hyllengren
No open positions remaining
Net worth: 185 155 $ as of 31/05/2026
Profile
Eric Hyllengren worked as Executive Director-Business Development at Amgen, Inc. from 2017 to 2018.
Mr. Hyllengren worked as Chief Financial, Operating & Accounting Officer at Atara Biotherapeutics, Inc. from 2024 to 2025.
Mr. Hyllengren worked as Chief Financial & Accounting Officer at Zura Bio Ltd. from 2025 to 2026.
Mr. Hyllengren completed undergraduate studies at the University of Notre Dame and earned an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/03/2026 | 17,617 ( 0.2% ) | 185 155 $ | 31/05/2026 |
Former positions of Eric Hyllengren
| Companies | Position | End |
|---|---|---|
| ZURA BIO LIMITED | Director of Finance/CFO | 20/04/2026 |
| ATARA BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 31/03/2025 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2018 |
Training of Eric Hyllengren
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Eric Hyllengren
Choose MarketScreener 
